Gene editing and production of 10GE pigs for preclinical and clinical studies
Thursday October 02, 2025 from 12:45 to 13:20
Auditorium
Presenter

David Ayares, United States

President and Chief Scientific Officer

Revivicor Inc.


© 2025 IXA 2025